Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
Web
NewsPlease enter a web search for web results.
News
WebJ&J's Stelara granted approval for pediatric ulcerative colitis (JNJ:NYSE)
2+ hour, 25+ min ago (22+ words) FDA expands Johnson & Johnson’s Stelara for pediatric ulcerative colitis (ages 2+), backed by clinical data and orphan drug status. Read more here....
HHS seeking public input on vaccine recommendation categories
1+ week, 5+ hour ago (17+ words) HHS seeks public input on CDC vaccine recommendation categories and whether changes are needed. Read more here....
New CDC director says vaccines are 'safe and effective"
1+ week, 2+ day ago (22+ words) CDC Director Erica Schwartz reassures staff vaccines are safe and effective, pledging to respect expertise and protect open dialogue. Read more here....
MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older Transcript
2+ mon, 4+ week ago (23+ words) MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older May 29, 2026 4:30 PM EDTCompany......
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade) (NYSE:USPH)
3+ mon, 6+ day ago (105+ words) Seeking Alpha - U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. - U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. - Management is…...
Pfizer begins late-stage trial for pneumococcal shot in infants
3+ mon, 1+ week ago (59+ words) Pfizer begins late-stage trial for new pneumococcal shot in infants after strong Phase 2 data Seeking Alpha Pfizer (PFE) on Wednesday announced that it has begun a Phase 3 trial for its 25-valent pneumococcal vaccine, PF-07872412 (25vPnC), for infants after the shot outperformed…...
Teen Jobs Holding Steady Going Into Summer Hiring Season
3+ mon, 2+ week ago (18+ words) The employment situation for U.S. teens held fairly steady in April 2026. Click here to read more....
Missouri appeals court upholds $495M ruling against Abbott in baby formula case
3+ mon, 3+ week ago (144+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to…...
SCHOLASTIC TO MARK 40 YEAR ANNIVERSARY OF ANN M. MARTIN'S BELOVED THE BABY-SITTERS CLUB® SERIES WITH EXCITING NEW PUBLISHING IN 2026 (2026-01-22)
7+ mon, 6+ day ago (201+ words) NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Nearly four decades since launching one of the most successful and beloved children's book series of all time, Scholastic, the global children's publishing, education, and media company, announced that it will release new titles to mark…...
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP) (2026-03-24)
5+ mon, 4+ day ago (434+ words) Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo BP is a chronic, relapsing skin disease with underlying type 2 inflammation characterized by intense…...